Therapeutic human albumin having a low aluminium binding capacit

Details Therapeutic human albumin having a low aluminium binding capacit Therapeutic human albumin having a low aluminium binding capacit

1997-01-24

1998-12-08

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 6, 514 12, 530362, 530363, 530364, A61K 3816, C07K 1300

Patent

active

058469303

ABSTRACT:
There is described a therapeutic human albumin having a very low capacity for the absorption of aluminium, during storage in a glass receptacle, wherein the final composition of the albumin solution adjusted to be stable and isotonic at a concentration of 5, 20 or 25% of protein in an aqueous medium, preferably, or to any other therapeutic concentration acceptable for intravenous administration, has a citrate content in the final albumin composition equal to or less than 0.5 mM (millimolar) and, preferably, less than 0.037 mM (millimolar).

REFERENCES:
patent: 4086222 (1978-04-01), Lindquist et al.
Klein, Gordon L.: Aluminum in Parenteral Products: Medical Perspective on Large and Small Volume Parenterals. Journal of Parenteral Science & Technology, 43 (3), 120-124 (1989).
Cuthbertson. B. et al.: Aluminium and Human Albumin Solutions. British Medical Journal, 295,1062 (1987).

Affiliated with

Also associated with

Rating

Therapeutic human albumin having a low aluminium binding capacit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic human albumin having a low aluminium binding capacit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic human albumin having a low aluminium binding capacit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-177232